Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

NCT02145923 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

16

Enrollment

OTHER_GOV

Sponsor class

Conditions

Neutropenic Enterocolitis
Myeloablative Chemotherapy Induced Bone Marrow Aplasia

Interventions

PROCEDURE: Peripheral blood stem cell mobilisation and collection
DRUG: High-dose chemotherapy
DRUG: Bone marrow derived allogeneic MMSCs infusion
PROCEDURE: Autologous peripheral blood stem cells infusion

Sponsor

Burnasyan Federal Medical Biophysical Center